1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6211)
  2. Journal Article (5696)
  3. Review (406)
  4. Book Section (187)
  5. Editorial (186)
  6. Research Letter (170)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13091)
  2. Department of Medicine (13007)
  3. Center for Hematologic Malignancies (10397)
  4. GSK Faculty (4423)
  5. Adult Leukemia (3584)
  6. Bone Marrow Transplant (2777)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (914)
  3. Ross Levine (776)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (205)
  2. 2024 (671)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1608)
  3. American Society of Clinical Oncology (1268)
  4. Nature Publishing Group (995)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13091)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase 2 trial of 28-day (Arm A) versus 14-Day (Arm B) schedule of venetoclax plus azacitidine in newly diagnosed acute myeloid leukemia patients ≥ 60 years
    Meeting Abstract

    Borate, U. M.; Huang, Y.; Johnson, M. F.; Zeidner, J. F.; Swords, R. T.; Koenig, K. L.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from istopmm, a population-based screening study in Iceland
    Meeting Abstract

    Rögnvaldsson, S.; Gasparini, A.; Thorsteinsdottir, S.; Sverrisdottir, I.; Eythorsson, E.; Long, T. E.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardottir, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Itacitinib for the prevention of immune effector cell therapy-associated cytokine release syndrome: Results from the phase 2 INCB 39110-211 placebo-controlled randomized cohort
    Meeting Abstract

    Frigault, M. J.; Maziarz, R. T.; Park, J. H.; Lazaryan, A.; Shah, N. N.; Svoboda, J.; Lekakis, L. J.; Reshef, R.; Phillips, C. L.; Burke, L. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is common in unrelated stem cell donors but has no impact on patient outcome after hematopoietic stem cell transplantation
    Meeting Abstract

    Schetelig, J.; Damm, F.; Günther, U. P.; Baldauf, H.; Rave, C.; Koster, L.; Schöfl, G.; Klussmeier, A.; Menghrajani, K.; Bolton, K. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Plasma circulating tumor DNA (ctDNA) as an alternative to tissue DNA for genotyping of DLBCL: Results from the POLARIX study
    Meeting Abstract

    Jardin, F.; Raghavan, V.; Tracy, S.; Balasubramanian, S.; Sehn, L. H.; Flowers, C. R.; Morschhauser, F.; Herrera, A. F.; Trněný, M.; Sharman, J. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The early benefits and psychological effects of screening for monoclonal gammopathy of undetermined significance: Results of the Istopmm study
    Meeting Abstract

    Rögnvaldsson, S.; Thorsteinsdottir, S.; Oskarsson, J.; Eythorsson, E.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardottir, M.; Olafsson, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of mutations in blood cancer-related genes on clinical outcomes in chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 tyrosine kinase inhibitors ( TKIs) in the Ascembl trial
    Meeting Abstract

    Branford, S.; Hochhaus, A.; Mauro, M.; Minami, Y.; Rea, D.; Freitas, Cmbd; Serrano-Fernandez, P.; Obourn, V.; Bruederle, A.; Espurz, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • RNA splicing factor mutations drive aberrant canonical and cryptic circular RNA biogenesis in leukemia
    Meeting Abstract

    Fernandez, M.; Jin, M.; Jia, Q.; Wu, Y.; Hart, K.; Bargoma, E.; Pangallo, J.; Bradley, R. K.; Abdel-Wahab, O.; Jia, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revised definition of free light chains in serum and light chain monoclonal gammopathy of undetermined significance: Results of the Istopmm study
    Meeting Abstract

    Long, T. E.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Sverrisdottir, I.; Eythorsson, E.; Indridason, O.; Palsson, R.; Aspelund, T.; Vidarsson, B.; Onundarson, P. T.; more...
    Blood (2023)

    Fulltext@MSK | Save